Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide 
Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic Focus
EMERYVILLE, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next...
Vaxart Reports First Quarter 2021 Financial Results and Provides Business Update
Vaxart to advance three oral tablet COVID-19 vaccine candidates to the clinic: VXA-CoV2-1 (includes both the S and the N...
Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financial Officer
SAN FRANCISCO, May 03, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies...
Krystal Biotech Appoints Andy Orth as Chief Commercial Officer
PITTSBURGH, May 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for...
The Pennant Group Acquires Texas Home Health Provider
EAGLE, Idaho, May 03, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant...
BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month
CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
BOTHELL, Wash., May 03, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company...
Neoleukin Therapeutics Announces Appointment of Priti Patel, M.D., M.S., as Chief Medical Officer
SEATTLE, May 03, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results
-- First U.S. commercial sales of IMCIVREE™ (setmelanotide) completed late in first quarter – -- Late-breaking data presentations at ENDO...
Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
- Data Showed AAVHSCs Edited Human Retinal Cell Types Across Two Targets - - Demonstrated 11 AAVHSC Capsids Crossed Blood-Retinal...
French National Cancer Institute and XBiotech Join forces to Conduct Innovative Phase II/III Adaptive Multicenter Clinical Study for XBiotech’s New Cancer Drug for Colorectal Cancer
XBiotech to Supply INSERM its New Drug to Use in Combination Therapy for Treating Advanced Colorectal CancerAUSTIN, Texas, May 03,...
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Increases Its Quarterly Dividend to $0.30 per Share
8.8% Increase in Fiscal 2021 Sales18.4% Increase in Fiscal 2021 Net Income9.7% Increase in Fiscal 2021 Reorder Sales DELRAY BEACH,...
Kymera Therapeutics Presents Positive Late-Breaking Data from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology 2021 Annual Meeting
Data provide further evidence for the central role of IRAK4 in inflammation in hidradenitis suppurativa and support both the degrader...
Neuronetics Employee Patient Advocates Honor Mental Health Awareness Month by Sharing Personal Depression Experiences
Employees who have found depression relief with NeuroStar Advanced Therapy for Mental Health use their voice to help othersMALVERN, Pa.,...
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
Company Prepares for Next Stage of GrowthFRAMINGHAM, Mass., May 03, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch”...
Mydecine Reports Full Year 2020 Financial Results and Provides Business Update
Positioned as Leader in Emerging Psychedelic Therapeutics Market through Robust IP Portfolio, Novel Clinical Trials and Evolving Proprietary Technology Strengthened...
ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by the United States Patent and Trademark Office
YONKERS, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...
Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2
COVAXIN effectively neutralizes Brazil variant along with UK variant and India double mutant variantPotential effectiveness against multiple variants reduces the...
AIM ImmunoTech CEO Thomas K. Equels Participates in Fireside Chat with Ascendiant Capital Markets Analyst Ed Woo
OCALA, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) announces that Thomas K. Equels, CEO...
Dosecann Launches Industry-Leading, High-Potency Topical: Dosecann Daily Relief CBD Cream
Dosecann Daily Relief CBD Cream Dosecann Daily Relief CBD Cream TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- Today Dosecann, an...